Unknown

Dataset Information

0

S-adenosylmethionine decreases lipopolysaccharide-induced phosphodiesterase 4B2 and attenuates tumor necrosis factor expression via cAMP/protein kinase A pathway.


ABSTRACT: S-Adenosylmethionine (SAM) treatment has anti-inflammatory, cytoprotective effects against endotoxin-induced organ injury. An important component of the anti-inflammatory action of SAM involves down-regulation of the lipopolysaccharide (LPS)-induced transcriptional induction of tumor necrosis factor-? (TNF) expression by monocytes/macrophages. We examined the effect of SAM on expression and activity of LPS-induced up-regulation of phosphodiesterase 4 (PDE4), which regulates cellular cAMP levels and TNF expression. LPS treatment of RAW 264.7, a mouse macrophage cell line, led to the induction of Pde4b2 mRNA expression with no effect on Pde4a or Pde4d. SAM pretreatment led to a significant decrease in LPS-induced up-regulation of Pde4b2 expression in both RAW 264.7 cells and primary human CD14(+) monocytes. Of note, the decreased Pde4b2 mRNA expression correlated with the SAM-dependent increase in the transcriptionally repressive histone H3 lysine 9 trimethylation on the Pde4b2 intronic promoter region. The SAM-mediated decrease in LPS-inducible Pde4b2 up-regulation resulted in an increase in cellular cAMP levels and activation of cAMP-dependent protein kinase A (PKA), which plays an inhibitory role in LPS-induced TNF production. In addition, SAM did not affect LPS-inducible inhibitor of nuclear factor-?B degradation or nuclear factor-?B (NF-?B)-p65 translocation into the nucleus but rather inhibited NF-?B transcriptional activity. These results demonstrate for the first time that inhibition of LPS-induced PDE4B2 up-regulation and increased cAMP-dependent PKA activation are significant mechanisms contributing to the anti-TNF effect of SAM. Moreover, these data also suggest that SAM may be used as an effective PDE4B inhibitor in the treatment of chronic inflammatory disorders in which TNF expression plays a significant pathogenic role.

SUBMITTER: Gobejishvili L 

PROVIDER: S-EPMC3083110 | biostudies-literature | 2011 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

S-adenosylmethionine decreases lipopolysaccharide-induced phosphodiesterase 4B2 and attenuates tumor necrosis factor expression via cAMP/protein kinase A pathway.

Gobejishvili Leila L   Avila Diana V DV   Barker David F DF   Ghare Smita S   Henderson David D   Brock Guy N GN   Kirpich Irina A IA   Joshi-Barve Swati S   Mokshagundam Sri Prakash L SP   McClain Craig J CJ   Barve Shirish S  

The Journal of pharmacology and experimental therapeutics 20110125 2


S-Adenosylmethionine (SAM) treatment has anti-inflammatory, cytoprotective effects against endotoxin-induced organ injury. An important component of the anti-inflammatory action of SAM involves down-regulation of the lipopolysaccharide (LPS)-induced transcriptional induction of tumor necrosis factor-α (TNF) expression by monocytes/macrophages. We examined the effect of SAM on expression and activity of LPS-induced up-regulation of phosphodiesterase 4 (PDE4), which regulates cellular cAMP levels  ...[more]

Similar Datasets

| S-EPMC1220431 | biostudies-other
| S-EPMC10552185 | biostudies-literature
| S-EPMC2653465 | biostudies-literature
| S-EPMC6717892 | biostudies-literature
2023-09-13 | PXD045088 | Pride
| S-EPMC4154116 | biostudies-literature
| S-EPMC8167433 | biostudies-literature
| S-EPMC5942793 | biostudies-literature
| S-EPMC3700720 | biostudies-literature
| S-EPMC1217414 | biostudies-other